Semaglutide 10mg (Ozempic)
Research Use Only
Research Use Only
For in vitro laboratory research by qualified professionals only. Not for human or animal administration. Not intended to treat, prevent, mitigate, or cure any disease. Batch-specific Certificates of Analysis available for all products.
Semaglutide is a long-acting GLP-1 receptor agonist peptide widely studied in metabolic research. Its modified structure provides extended stability, making it valuable for research into glucose homeostasis and appetite regulation pathways.
Related Research News
Semaglutide News: Ozempic Linked to Fewer Bone Fractures Despite Greater Weight Loss
Recent data presented at the American Diabetes Association annual meeting suggests semaglutide (Ozempic, Wegovy) may reduce bone fracture risk even with significant weight loss. This semaglutide news adds a new dimension to GLP-1 research, with implications for metabolic and skeletal health.
Semaglutide News: Ozempic Linked to Fewer Bone Fractures Despite Greater Weight Loss
New data presented at the American Diabetes Association annual meeting suggests semaglutide (Ozempic, Wegovy) may reduce bone fracture risk, even with significant weight loss. The findings add a new layer to the safety profile of GLP-1 receptor agonists and have implications for peptide research.
Ozempic and Wegovy linked to drop in violent behavior, study finds
A new study has found that the popular GLP-1 drugs Ozempic and Wegovy are linked to a decrease in violent behavior among users. The research, reported by NewsNation, adds to the growing body of evidence suggesting these medications may have broader effects beyond weight loss and blood sugar control.
Explore Research
Peptide Tools
Frequently Bought Together
Semaglutide 10mg
10mg
$49 USD
Bundle & Save
$149 USD
Save $9 USD
$214 USD
Save $19 USD
$244 USD
Save $39 USD
$344 USD
Save $69 USD
Click any product above to toggle selection
Related Peptides
Someone in Tampa, FL purchased
GHK-Cu 50mg
18 minutes ago